CRH Form 144: 7,502 Shares Vesting

CRH public limited company filed a Form 144 notice for the proposed sale of 7,502 ordinary shares of €0.32 each tied to the vesting of a time-based equity award on 02/23/2026.

Rhea-AI Filing Summary

CRH public limited company filed a Form 144 notice for the proposed sale of 7,502 ordinary shares of €0.32 each tied to the vesting of a time-based equity award on 02/23/2026.

The filing lists the securities as Ordinary Shares traded on NYSE and identifies the event as Vesting of Time-based Equity Award with an action labeled "Services rendered." The notice documents the affiliate sale mechanics common to such vesting events; timing and method of any sale are not specified in the excerpt.

Insights

Equity Compensation Analyst

Form 144 documents a routine affiliate notice tied to a vesting equity award.

The excerpt lists 7,502 ordinary shares of €0.32 each that vest on 02/23/2026 and are identified under "Vesting of Time-based Equity Award." This indicates a compensatory issuance event rather than an operational transaction.

Cash-flow treatment and sale method are absent in the excerpt. Subsequent SEC notices or brokery disclosures may provide sale timing or execution details; until then, the effect on share count or float cannot be assessed from the provided lines.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does CRH's Form 144 notice report?

It reports a proposed sale of 7,502 ordinary shares tied to a time-based equity award vesting on 02/23/2026. The notice documents an affiliate disposition filing related to vested compensation; the filing lists NYSE as the trading market.

Does the Form 144 show who will receive proceeds from the sale for CRH?

The excerpt does not assign proceeds; it only records a proposed sale of vested shares on 02/23/2026. The filing text provided does not state whether proceeds go to the issuer or selling holder.

How many CRH shares are involved and what is the share class?

The notice covers 7,502 ordinary shares of €0.32 par value each. The filing labels them as Ordinary Shares traded on the NYSE and tied to a vesting award.

Does this Form 144 indicate an immediate market sale by an insider?

No immediate sale is documented; the filing records a proposed sale tied to vesting on 02/23/2026. The excerpt does not disclose execution method, timing, or any broker arrangements.

Is the vesting event listed as compensatory for CRH?

Yes. The filing explicitly identifies the transaction as "Vesting of Time-based Equity Award" and notes "Services rendered," indicating a compensatory issuance tied to service.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/23/2026 - 08:56 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002013082
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CRH public limited company
SEC File Number	001-32846
Address of Issuer	Stonemason's Way, Rathfarnham Dublin 16 IRELAND D16 KH51
Phone	353-1-404-1000
Name of Person for Whose Account the Securities are To Be Sold	Mintern, Denis James
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary Shares of EURO 0.32 each	Davy Group 49 Dawson Street Dublin 2 Dublin L2 D02 YX20	7502	930548.08	668250818	02/23/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary Shares of Euro 0.32 each	02/23/2026	Vesting of Time-based Equity Award	CRH public limited company			7502	02/23/2026	Services rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/23/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Neil Colgan, Attorney-in-Fact for Denis James Mintern
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)